cercosporamide has been researched along with cgp 57380 in 2 studies
| Studies (cercosporamide) | Trials (cercosporamide) | Recent Studies (post-2010) (cercosporamide) | Studies (cgp 57380) | Trials (cgp 57380) | Recent Studies (post-2010) (cgp 57380) |
|---|---|---|---|---|---|
| 26 | 0 | 20 | 64 | 0 | 44 |
| Protein | Taxonomy | cercosporamide (IC50) | cgp 57380 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | 2.7 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Homo sapiens (human) | 3.2 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 1.6 | |
| Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 2.5 | |
| Eukaryotic translation initiation factor 4E | Homo sapiens (human) | 3 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.6 | |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 5 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 0.51 | |
| Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | 1.1 | |
| Aurora kinase B | Homo sapiens (human) | 2.5 | |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | 1.2182 | |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 2.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kannan, S; Nacro, K; Verma, CS; Xu, W | 1 |
| Alarcon, H; Borrell, JI; Bou-Petit, E; Cano-Galietero, M; Estrada-Tejedor, R; Fuentes, P; Guijarro, PJ; Hümmer, S; Muñoz, MJ; Ramón Y Cajal, S; Santamaria, A; Slobodnyuk, K; Suarez-Cabrera, L | 1 |
1 review(s) available for cercosporamide and cgp 57380
| Article | Year |
|---|---|
Update on the Development of MNK Inhibitors as Therapeutic Agents.
Topics: Animals; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Neoplasms; Nervous System Diseases; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2022 |
1 other study(ies) available for cercosporamide and cgp 57380
| Article | Year |
|---|---|
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.
Topics: Adenosine Triphosphate; Intracellular Signaling Peptides and Proteins; Models, Molecular; Protein Serine-Threonine Kinases; Signal Transduction | 2022 |